MCID: ATT020
MIFTS: 12

Attention Deficit-Hyperactivity Disorder 2

Categories: Genetic diseases, Mental diseases

Aliases & Classifications for Attention Deficit-Hyperactivity Disorder 2

MalaCards integrated aliases for Attention Deficit-Hyperactivity Disorder 2:

Name: Attention Deficit-Hyperactivity Disorder 2 57
Attention Deficit-Hyperactivity Disorder, Susceptibility to, 2 57 13
Adhd2 57

Classifications:



External Ids:

OMIM 57 608904

Summaries for Attention Deficit-Hyperactivity Disorder 2

MalaCards based summary : Attention Deficit-Hyperactivity Disorder 2, also known as attention deficit-hyperactivity disorder, susceptibility to, 2, is related to attention deficit-hyperactivity disorder. An important gene associated with Attention Deficit-Hyperactivity Disorder 2 is ADHD2 (Attention Deficit-Hyperactivity Disorder, Susceptibility To, 2). The drugs Ethanol and Central Nervous System Depressants have been mentioned in the context of this disorder.

Description from OMIM: 608904

Related Diseases for Attention Deficit-Hyperactivity Disorder 2

Diseases in the Attention Deficit-Hyperactivity Disorder family:

Attention Deficit-Hyperactivity Disorder 1 Attention Deficit-Hyperactivity Disorder 2
Attention Deficit-Hyperactivity Disorder 3 Attention Deficit-Hyperactivity Disorder 4

Diseases related to Attention Deficit-Hyperactivity Disorder 2 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 attention deficit-hyperactivity disorder 11.2

Symptoms & Phenotypes for Attention Deficit-Hyperactivity Disorder 2

Clinical features from OMIM:

608904

Drugs & Therapeutics for Attention Deficit-Hyperactivity Disorder 2

Drugs for Attention Deficit-Hyperactivity Disorder 2 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved 64-17-5 702
2 Central Nervous System Depressants
3 Detox adjuvant
4 Anti-Infective Agents
5 Anti-Infective Agents, Local

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Software Treatment for Actively Reducing Severity of ADHD - Follow Up Completed NCT02828644 Not Applicable
2 Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children Recruiting NCT03436017
3 ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse Recruiting NCT02364817

Search NIH Clinical Center for Attention Deficit-Hyperactivity Disorder 2

Genetic Tests for Attention Deficit-Hyperactivity Disorder 2

Anatomical Context for Attention Deficit-Hyperactivity Disorder 2

Publications for Attention Deficit-Hyperactivity Disorder 2

Variations for Attention Deficit-Hyperactivity Disorder 2

Expression for Attention Deficit-Hyperactivity Disorder 2

Search GEO for disease gene expression data for Attention Deficit-Hyperactivity Disorder 2.

Pathways for Attention Deficit-Hyperactivity Disorder 2

GO Terms for Attention Deficit-Hyperactivity Disorder 2

Sources for Attention Deficit-Hyperactivity Disorder 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....